01643 MODERN CHI MED
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 8.54X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | N/A | Net Margin | N/A |
| Total Debt/Equity | 0.0% | Return on Equity | N/A |
| Price/Book | 2.61X | Return on Assets | N/A |
| (HKD 2.010) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | -15.09 | 10.28 | 53.78 | 98.47 | 100.02 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -246.7 | -80.9 | -45.4 | -1.6 | +32.6 |
| Earnings Per Share (HKD) | -0.023 | 0.017 | 0.09 | 0.164 | 0.168 |
| Earnings Per Share Growth (%) | -233.9 | -80.9 | -45.4 | -2.6 | +0.4 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | 0.017 |
| P/E* (X) | N/A | 117.54 | 22.43 | 12.25 | 11.94 |
| Yield (%) | N/A | N/A | N/A | N/A | 0.83 |
| Dividend Share (%) | N/A | N/A | N/A | N/A | 9.92 |
| Book NAV (HKD) | 0.770 | 0.858 | 0.869 | 0.790 | 0.688 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 145.174 | 214.068 | -32.2 | 344.075 |
| Operating Result | -14.021 | 23.408 | -159.9 | 68.306 |
| Profit Before Taxation | -14.021 | 14.819 | -194.6 | 68.306 |
| Taxation | -0.464 | 5.149 | -109.0 | 19.511 |
| Profit /( Loss) After Taxation | -13.557 | 9.67 | -240.2 | 48.795 |
| Net Profit | -13.557 | 9.67 | -240.2 | 48.795 |
| Earnings Per Share () | -0.0229 | 0.0171 | -233.9 | 0.0896 |
| Dividend Per Share () | 0.0000 | 0.0000 | N/A | 0.0000 |
| Announcement Date | 2026-03-30 | 2025-03-26 | NA | 2024-03-22 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
